GleamWall
中文EN

IOSP INNOSPEC INC.

Chemicals & Allied Products · Nasdaq · SEC CIK 1054905 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY4.7%
TTM net income YoY2,749.1%
TTM EPS YoY14,250.0%
Revenue 3-yr CAGR-1.6%
Net income 3-yr CAGR3.4%

Margins

Gross margin27.7%
Operating margin8.8%
Net margin7.5%
FCF margin2.5%
EBITDA margin10.9%

Returns

ROE10.5%
ROA7.7%
ROIC (approx.)12.4%
Asset turnover1.03x

Leverage & solvency

Liabilities / assets25.7%
Debt / equity0.00x
Current ratio2.95x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.74x
Accruals ratio2.0%
Payout ratio—
Capex / revenue3.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$473.60M$491.40M$453.20M$455.60M$441.90M$439.70M$440.80M$466.80M
Cost of revenue$344.50M$353.10M$329.70M$328.20M$325.20M$316.50M$315.70M$330.60M
Gross profit$129.10M$138.30M$123.50M$127.40M$116.70M$123.20M$125.10M$136.20M
R&D expense$16.80M$14.20M$13.20M$11.00M$13.70M$13.60M$12.70M$14.90M
SG&A expense$71.70M$84.30M$78.50M$69.30M$71.90M$74.60M$69.30M$78.90M
Operating income$41.70M$39.70M$36.50M$46.80M$5.90M$34.30M$42.50M$41.10M
Pretax income$42.60M$41.60M$39.90M$49.30M$11.30M$32.30M$45.20M-$102.60M
Income tax$11.00M$10.40M$9.10M$2.90M-$1.40M$8.40M$11.60M-$32.20M
Net income$31.80M$30.80M$30.40M$47.40M$12.90M$23.50M$32.80M-$74.50M
EBITDA$51.30M$49.70M$46.40M$56.20M$18.10M$45.40M$53.40M$52.00M
EPS (basic)1.291.251.23—0.520.941.31—
EPS (diluted)1.291.251.22—0.520.941.31—
Dividends declared per share0.000.84—0.870.000.76—0.79
Weighted avg. shares (diluted)24.74M24.71M24.84M—24.91M25.04M25.10M—
Balance sheet
Cash & equivalents$251.90M$250.20M$289.10M$292.50M$270.80M$266.60M$299.80M$289.20M
Receivables$395.60M$408.60M$354.20M$342.30M$349.50M$336.10M$343.50M$341.70M
Inventory$361.80M$337.30M$321.50M$329.30M$345.20M$336.80M$315.40M$301.00M
Current assets$1.03B$1.02B$999.10M$1.00B$988.80M$969.70M$977.10M$956.60M
PP&E, net$300.20M$293.30M$285.70M$286.10M$278.60M$295.80M$277.10M$269.70M
Goodwill$397.40M$398.20M$399.10M$399.00M$399.80M$397.60M$388.40M$382.50M
Intangibles$62.50M$65.30M$68.90M$67.70M$63.30M$78.30M$72.80M$65.40M
Total assets$1.86B$1.85B$1.82B$1.83B$1.80B$1.81B$1.77B$1.73B
Current liabilities$351.20M$368.10M$334.80M$360.10M$356.10M$337.40M$357.60M$371.40M
Total liabilities$476.30M$495.20M$467.60M$499.50M$496.50M$504.60M$508.90M$518.60M
Shareholders' equity$1.37B$1.34B$1.34B$1.33B$1.30B$1.30B$1.26B$1.21B
Cash flow statement
Operating cash flow$17.40M$7.20M$17.60M$61.40M$39.10M$9.30M$28.30M$25.70M
Capital expenditure$15.80M$17.70M$8.90M$14.60M$14.30M$13.00M$8.40M$12.10M
Free cash flow$1.60M-$10.50M$8.70M$46.80M$24.80M-$3.70M$19.90M$13.60M
Investing cash flow-$15.60M-$16.50M-$13.70M-$19.20M-$24.20M-$16.20M-$15.50M-$20.60M
Financing cash flow$100,000-$29.50M-$6.60M-$20.60M-$10.60M-$28.70M-$3.80M-$17.80M
Depreciation & amortization$9.60M$10.00M$9.90M$9.40M$12.20M$11.10M$10.90M$10.90M
Stock-based compensation$3.70M$4.90M$1.60M$3.10M$1.60M$2.50M$1.90M$2.10M
Dividends paid$0——$21.60M$0——$19.80M
Share buybacks$0$6.40M$7.10M$0$10.60M$8.50M$4.80M$0

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.